Business

Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

NEWARK, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) today announced revised subscription rights in connection with its previously announced rights offering. Holders of record as of May 9, 2025 (the “Record Date”) will be eligible to participate in the rights offering. To be considered a Holder of record on the Record Date, prospective Holders must complete open market purchases by May 8, 2025. Former holders of Cyclo Therapeutics, Inc. who did

articleRafael Holdings, Inc.May 5, 20256/company/rafael-holdings-inc/news/rafael-holdings-inc-announces-revised-110000848
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

About this update from Rafael Holdings, Inc.

[{"type":"image","alt":"Rafael Holdings, Inc.","displaySize":"","headline":null,"caption":"Rafael Holdings, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":179,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/135483f9ca0ce750d79c23f2fecb7eff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/czMSfXYLjlvGAI3Ot9zW5Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTcyO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/135483f9ca0ce750d79c23f2fecb7eff","width":179,"height":61}},"lazy":false},{"type":"text","content":"NEWARK, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) today announced revised subscription rights in connection with its previously announced rights offering.","length":208,"tagName":"p"},{"type":"text","content":"Holders of record as of May 9, 2025 (the “Record Date”) will be eligible to participate in the rights offering. To be considered a Holder of record on the Record Date, prospective Holders must complete open market purchases by May 8, 2025.","length":239,"tagName":"p"},{"type":"text","content":"Former holders of Cyclo Therapeutics, Inc. who did not hold shares in street name and have not submitted their letter of transmittal to Equiniti Trust Company LLC (the Company’s transfer agent), and wish to participate in the rights offering, should send their letter of transmittal to Equiniti and complete the steps to exchange their Cyclo common stock for Class B common stock of the Company as soon as possible, as they must be record holders of Class B common stock prior to the Record Date in order to participate in the rights offering.","length":543,"tagName":"p"},{"type":"text","content":"Rights Offering Details","length":23,"tagName":"p"},{"type":"text","content":"Under the proposed rights offering, Rafael Holdings intends to distribute one (1) non-transferable subscription right for each share of Class B Common Stock or Class A Common Stock or share of Class B Common Stock purchasable on exercise of Public Warrants, in each case, held as of the Record Date. Each subscription right will entitle the Holder to purchase 0.603 of a share of Class B Common Stock at a subscription price of $1.28 per share. Subscription rights may only be exercised in whole numbers, and fractional shares will not be issued. The number of shares that may be purchased by each hold...

More updates from Rafael Holdings, Inc.

Rafael Holdings, Inc.subscription rightsRafael Holdingsrights offeringprospective HoldersCyclo Therapeutics, Inc.common stockRecord Datesubscription periodCompany